Synchronized proliferation induced by 12-O-tetradecanoylphorbol- 13- acetate treatment of mouse skin: An in vivo model for cell cycle regulation

Cell Growth and Differentiation

Volumn 9, Issue 1, 1998, Pages 31-39

  Rodriguez Puebla, Marcelo L ^a   Robles, Ana I ^a   Johnson, David G ^a   LaCava, Margaret ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; CELL CYCLE; CELL DIVISION; CYCLINS; FEMALE; KERATINOCYTES; MICE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SKIN; TETRADECANOYLPHORBOL ACETATE;

EID: 0031964722     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell, 79: 547-550, 1994.
2. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
3. Sherr, C. J. Mammalian G, cyclins. Cell, 73: 1059-1065, 1993.
4. 1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1693, 1992.
5. 1 phase progression: cyclin on cue. Cell, 79: 551-555, 1994.
6. cdc2 and a possible mechanism for its periodic activation. Cell, 57: 253-263, 1989.
7. Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C., Matera, A. G., and Xiong, Y. Growth suppression by p18, a p16- and p15-related CDK6 inhibitor, correlates with wild-type pRb functions. Genes Dev., 8: 2939-2952, 1994.
8. NK4D is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 377: 257-261, 1994.
9. Demers, G. W., Foster, S. A., Halbert, C. L., and Galloway, D. A. Growth arrest by induction of p53 in DNA-damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA, 91: 4382-4386, 1994.
10. Sherr, C.J. D-type cyclins. Trends Biochem Sci. 20:187-190, 1995.
11. Munger, K., Pieternpol. J. A., Pittelkow, M. R., Holt, J. T., and Moses, H. L. Transforming growth factor β1 regulation of c-myc expression, pRb phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ., 3: 291-298, 1992.
12. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
13. Kato, J-Y., Matsuoka, M., Strom, D. K., and Sherr, C. J. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol., 14: 2713-2721, 1994.
14. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Gell. Biol., 14: 2077-2086, 1994.
15. Kress, S., Sutter, C., Strickland, P. T., Mukhtar, H., Schweizer, J., and Schwarz, M. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res., 52: 6400-6403, 1992.
16. Ruggeri, B., Caamano, J., and Goodrow, T. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res., 51: 6615-6621, 1991.
17. Robles, A. I., and Conti, C.J. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (Lond.), 16:781-786, 1995.
18. Bianchi, A. B., Fischer, S. M., Rubles, A. I., Rinchik, E. M., and Conti, C. J. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene, 8: 1127-1133, 1993.
19. Chen, Y., Robles, A. I., Martinez, L., Liu, F., Gimenez-Conti, I., and Conti, C. J. Expression of G, cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ., 7: 1571-1578, 1996.
20. Waf1/Cip1 and p53 in sun-exposed normal epidermis, but not in neoplastic epidermis. Br. J. Dermatol., 135: 717-720, 1996.
21. Albrecht, J. H., Hu, M. Y., and Cerra, F. B. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun., 209: 648-655, 1995.
22. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L., and Guguen-Guillouzo, C. Expression and activation of CDKs (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem., 269: 2491-2500, 1994.
23. Lu, X. P., Koch, K. S., Lew, D., Dulic, V., Pines, J., Reed, S., Hunter, T., and Leffer, H. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J. Biol. Chem., 267:2841-2844, 1992.
24. Cen, D., and Levin, J. Cell cycle status of murine megakaryocyte and granulocyte macrophage colony-forming cells in bone marrow and spleen. Exp. Hematol., 20: 1094-1100, 1992.
25. Raick, A., Thum, K., and Chivers, B. Early effects of 12-O-tetradecanoylphorbol-13-acetate on the incorporation of tritiated precursors into DNA, and the thickness of the intrafollicular epidermis, and their relation to tumor promotion in mouse skin. Cancer Res., 32: 1562-1568, 1972.
26. Kaczmarek, L., Hyland, J. K., Watt, R., Rosenberg, M., and Baserga, R. Microinjected c-myc as a competence factor. Science (Washington DC), 228: 1313-1315, 1985.
27. Eilers, M., Schirm, S., and Bishop, J. M. The Myc protein activates transcription of the prothymosin gene. EMBO J., 70: 133-141, 1991.
28. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J., 77: 961-971, 1992.
29. Noguchi, E., Sekiguchi, T., Yamashita, K., and Nishimoto, T. Molecular cloning and identification of two types of hamster cyclin-dependent kinases: CDK2 and CDK2L. Biochem. Biophys. Res. Commun., 197: 1524-1529, 1993.
30. Xiong, Y. Why are there so many CDK inhibitors? Biochim. Biophys. Acta, 1288: 1-5, 1996.
31. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin S/cdk4. Nature (Lond.), 366: 704-707, 1993.
32. Xiong. Y., Zhang, H., and Beach, D. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 77: 505-514, 1992.
33. 1, cyclins. Cell, 77: 323-334, 1992.
34. Hannon, G. J., Demetrick, D., and Beach, D. Isolation of the Rbrelated p130 through its interaction with CDK2 and cyclins. Genes Dev., 7: 2378-2391, 1993.
35. Hurford, R., Cobrinik, D., Lee, M-H., and Dysion, N. pRb and p107/ p130 are required for the regulated expression of different sets of E2F-responsive genes. Genes Dev., 11: 1447-1463, 1997.
36. Johnson, D. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene, 11: 1685-1692, 1995.
37. Mayol, X., Garriga, J., and Grana, X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene, 11: 801808, 1995.
38. 0 lead to its association with E2F-4. Oncogene, 13: 237-246, 1996.
39. Ewen, M. E., Xing, Y. G., Lawrence, J. B., and Livingston, D. M. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66. 1155-1164, 1991.
40. Elgjo, K. Epidermal cell population kinetics after a single application of some hyperplasia-producing substances. Eur. J. Cancer, 3: 519-521, 1968.
41. Iversen, O. H., and Bjerkbes, R. Kinetics of epidermal reaction to carcinogens. Acta Pathol. Microbiol. Scand., (Suppl.): 165, 1963.
42. Fukuda, M., Okamura, K., Rohrbrach, R., Bohm, N., and Fujita, S. Changes in cell population kinetics during epidermal carcinogenesis. Cell Tissue Kinet., 11: 611-621, 1978.
43. Pines, J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J., 308: 697-711, 1995.
44. 1-S phase transition by expression of cyclin D1 and E with inducible system. Mol. Cell Biol., 14: 1669-1679, 1994.
45. Matsushine, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J. Y. D-type cyclin-dependent kinases activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
46. Yuspa, S. H., Ben, T., Hennings, H., and Lichti, U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 42: 2344-2349, 1982.
47. Yuspa, S. H. Cutaneous carcinogenesis: natural and experimental. In: L. Goldsmith (ed.), Biochemistry and Physiology of the Skin, pp. 66-76. Oxford, United Kingdom: Oxford University Press, 1982.
48. Coppock, D. L., Tansey, J. B., Scandalis, S., and Nathanson, L. Phorbol esters and growth regulation in metastatic melanoma cells. Cancer Treat. Res., 54: 67-83, 1991.
49. kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9: 639-649, 1995.
50. Gartel, A., Serfas, M., and Tyner, A. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med., 213: 138-149, 1996.
51. Evers, B., Ko, T., Li, J., and Thompson, E. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am. J. Physiol., 277: G722-G727, 1996.
52. Quo, K., Wang, J., Andres, V., Smith, R., and Walsh, K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol., 15: 3823-3829, 1995.
53. Harper, J., Elledge, S., Keyomarsi, K., Dynlacht, B., Tsai, L., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowtey, L., and Swindell, E. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6:387-400, 1995.
54. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi. R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
55. WAF1/cIp1 expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
56. Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267:1024-1027, 1995.
57. kip2 gene at 11p15.5. Oncogene, 12:1365-1368, 1996.
58. Kip2 on chromosome 11p15. Proc. Natl. Acad. Sci. USA, 93: 3026-3030, 1996.
59. Kip2, a cyclin-dependent kinase inhibitor in mouse. Nat. Genet., 11: 204-206, 1995.
60. Bianchi, A. B., Navone, N. M., Aldaz, C. M., and Conti, C. J. Over-lapping toss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis. Proc. Natl. Acad. Sci. USA, 88: 7590-7594, 1991.
61. Grana, X., and Reddy, P. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases, growth suppressor genes, and cyclin-dependent kinase inhibitors. Oncogene, 11: 211-219, 1995.
62. Nevins, J. Cell cycle targets of the DMA tumor viruses. Curr. Opin. Genet. Dev., 4: 130-134, 1994.
63. Zhu, L., Zhu, L., Xie, E., and Chang, L-S. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell. Biol., 15: 3552-3562, 1995.
64. Shan, B., Chang, C-Y., Jones, D., and Lee, W-H. The transcription factor E2F-1 mediates the autoregulation of Rb gene expression. Mol. Cell. Biol., 14: 299-309, 1994.